Selected research
Industry Research
Short-acting Nicotine Product Industry Research Report 2026
Market perspective
The global Short-acting Nicotine Product market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Short-acting Nicotine Product is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Short-acting Nicotine Product is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Short-acting Nicotine Product is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Short-acting Nicotine Product include Nicorette (Johnson & Johnson), Nicotinell (Haleon), Equate (Walmart), Thrive (Haleon), NiQuitin (Perrigo), Philip Morris, Alkalon, LUCY GOODS and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Short-acting Nicotine Product market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Short-acting Nicotine Product Market by Company
Nicorette (Johnson & Johnson)
Nicotinell (Haleon)
Equate (Walmart)
Thrive (Haleon)
NiQuitin (Perrigo)
Philip Morris
Alkalon
LUCY GOODS
Dr. Reddy's Laboratories
Nicotex (Cipla Health)
Swedish Match
Altria
British American Tobacco (BAT)
Skruf Snus
Japan Tobacco International (JTI)
Short-acting Nicotine Product Segment by Type
Nicotine Gum
Nicotine Lozenge
Nasal Spray
Oral Inhaler
Nicotine Pouches
Short-acting Nicotine Product Segment by Application
Online Sales
Offline Sales
Short-acting Nicotine Product Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Short-acting Nicotine Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Short-acting Nicotine Product and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Short-acting Nicotine Product.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Short-acting Nicotine Product manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Short-acting Nicotine Product by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Short-acting Nicotine Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nicotine Gum
- Nicotine Lozenge
- Nasal Spray
- Oral Inhaler
- Nicotine Pouches
Applications
- Online Sales
- Offline Sales
Companies covered
- Nicorette (Johnson & Johnson)
- Nicotinell (Haleon)
- Equate (Walmart)
- Thrive (Haleon)
- NiQuitin (Perrigo)
- Philip Morris
- Alkalon
- LUCY GOODS
- Dr. Reddy's Laboratories
- Nicotex (Cipla Health)
- Swedish Match
- Altria
- British American Tobacco (BAT)
- Skruf Snus
- Japan Tobacco International (JTI)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Short-acting Nicotine Product Market Size (2021-2032)
- 2.2.2 Global Short-acting Nicotine Product Sales (2021-2032)
- 2.2.3 Global Short-acting Nicotine Product Market Average Price (2021-2032)
- 2.3 Short-acting Nicotine Product by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Nicotine Gum
- 2.3.3 Nicotine Lozenge
- 2.3.4 Nasal Spray
- 2.3.5 Oral Inhaler
- 2.3.6 Nicotine Pouches
- 2.4 Short-acting Nicotine Product by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Sales
- 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Short-acting Nicotine Product Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Short-acting Nicotine Product Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Short-acting Nicotine Product Revenue of Manufacturers (2021-2026)
- 3.4 Global Short-acting Nicotine Product Average Price by Manufacturers (2021-2026)
- 3.5 Global Short-acting Nicotine Product Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Short-acting Nicotine Product, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Short-acting Nicotine Product, Product Type & Application
- 3.8 Global Manufacturers of Short-acting Nicotine Product, Established Date
- 3.9 Global Short-acting Nicotine Product Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Nicorette (Johnson & Johnson)
- 4.1.1 Nicorette (Johnson & Johnson) Company Information
- 4.1.2 Nicorette (Johnson & Johnson) Business Overview
- 4.1.3 Nicorette (Johnson & Johnson) Short-acting Nicotine Product Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Nicorette (Johnson & Johnson) Short-acting Nicotine Product Product Portfolio
- 4.1.5 Nicorette (Johnson & Johnson) Recent Developments
- 4.2 Nicotinell (Haleon)
- 4.2.1 Nicotinell (Haleon) Company Information
- 4.2.2 Nicotinell (Haleon) Business Overview
- 4.2.3 Nicotinell (Haleon) Short-acting Nicotine Product Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Nicotinell (Haleon) Short-acting Nicotine Product Product Portfolio
- 4.2.5 Nicotinell (Haleon) Recent Developments
- 4.3 Equate (Walmart)
- 4.3.1 Equate (Walmart) Company Information
- 4.3.2 Equate (Walmart) Business Overview
- 4.3.3 Equate (Walmart) Short-acting Nicotine Product Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Equate (Walmart) Short-acting Nicotine Product Product Portfolio
- 4.3.5 Equate (Walmart) Recent Developments
- 4.4 Thrive (Haleon)
- 4.4.1 Thrive (Haleon) Company Information
- 4.4.2 Thrive (Haleon) Business Overview
- 4.4.3 Thrive (Haleon) Short-acting Nicotine Product Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Thrive (Haleon) Short-acting Nicotine Product Product Portfolio
- 4.4.5 Thrive (Haleon) Recent Developments
- 4.5 NiQuitin (Perrigo)
- 4.5.1 NiQuitin (Perrigo) Company Information
- 4.5.2 NiQuitin (Perrigo) Business Overview
- 4.5.3 NiQuitin (Perrigo) Short-acting Nicotine Product Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 NiQuitin (Perrigo) Short-acting Nicotine Product Product Portfolio
- 4.5.5 NiQuitin (Perrigo) Recent Developments
- 4.6 Philip Morris
- 4.6.1 Philip Morris Company Information
- 4.6.2 Philip Morris Business Overview
- 4.6.3 Philip Morris Short-acting Nicotine Product Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Philip Morris Short-acting Nicotine Product Product Portfolio
- 4.6.5 Philip Morris Recent Developments
- 4.7 Alkalon
- 4.7.1 Alkalon Company Information
- 4.7.2 Alkalon Business Overview
- 4.7.3 Alkalon Short-acting Nicotine Product Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Alkalon Short-acting Nicotine Product Product Portfolio
- 4.7.5 Alkalon Recent Developments
- 4.8 LUCY GOODS
- 4.8.1 LUCY GOODS Company Information
- 4.8.2 LUCY GOODS Business Overview
- 4.8.3 LUCY GOODS Short-acting Nicotine Product Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 LUCY GOODS Short-acting Nicotine Product Product Portfolio
- 4.8.5 LUCY GOODS Recent Developments
- 4.9 Dr. Reddy's Laboratories
- 4.9.1 Dr. Reddy's Laboratories Company Information
- 4.9.2 Dr. Reddy's Laboratories Business Overview
- 4.9.3 Dr. Reddy's Laboratories Short-acting Nicotine Product Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Dr. Reddy's Laboratories Short-acting Nicotine Product Product Portfolio
- 4.9.5 Dr. Reddy's Laboratories Recent Developments
- 4.10 Nicotex (Cipla Health)
- 4.10.1 Nicotex (Cipla Health) Company Information
- 4.10.2 Nicotex (Cipla Health) Business Overview
- 4.10.3 Nicotex (Cipla Health) Short-acting Nicotine Product Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Nicotex (Cipla Health) Short-acting Nicotine Product Product Portfolio
- 4.10.5 Nicotex (Cipla Health) Recent Developments
- 4.11 Swedish Match
- 4.11.1 Swedish Match Company Information
- 4.11.2 Swedish Match Business Overview
- 4.11.3 Swedish Match Short-acting Nicotine Product Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Swedish Match Short-acting Nicotine Product Product Portfolio
- 4.11.5 Swedish Match Recent Developments
- 4.12 Altria
- 4.12.1 Altria Company Information
- 4.12.2 Altria Business Overview
- 4.12.3 Altria Short-acting Nicotine Product Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Altria Short-acting Nicotine Product Product Portfolio
- 4.12.5 Altria Recent Developments
- 4.13 British American Tobacco (BAT)
- 4.13.1 British American Tobacco (BAT) Company Information
- 4.13.2 British American Tobacco (BAT) Business Overview
- 4.13.3 British American Tobacco (BAT) Short-acting Nicotine Product Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 British American Tobacco (BAT) Short-acting Nicotine Product Product Portfolio
- 4.13.5 British American Tobacco (BAT) Recent Developments
- 4.14 Skruf Snus
- 4.14.1 Skruf Snus Company Information
- 4.14.2 Skruf Snus Business Overview
- 4.14.3 Skruf Snus Short-acting Nicotine Product Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Skruf Snus Short-acting Nicotine Product Product Portfolio
- 4.14.5 Skruf Snus Recent Developments
- 4.15 Japan Tobacco International (JTI)
- 4.15.1 Japan Tobacco International (JTI) Company Information
- 4.15.2 Japan Tobacco International (JTI) Business Overview
- 4.15.3 Japan Tobacco International (JTI) Short-acting Nicotine Product Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Japan Tobacco International (JTI) Short-acting Nicotine Product Product Portfolio
- 4.15.5 Japan Tobacco International (JTI) Recent Developments
5 Global Short-acting Nicotine Product Market Scenario by Region
- 5.1 Global Short-acting Nicotine Product Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Short-acting Nicotine Product Sales by Region: 2021-2032
- 5.2.1 Global Short-acting Nicotine Product Sales by Region: 2021-2026
- 5.2.2 Global Short-acting Nicotine Product Sales by Region: 2027-2032
- 5.3 Global Short-acting Nicotine Product Revenue by Region: 2021-2032
- 5.3.1 Global Short-acting Nicotine Product Revenue by Region: 2021-2026
- 5.3.2 Global Short-acting Nicotine Product Revenue by Region: 2027-2032
- 5.4 North America Short-acting Nicotine Product Market Facts & Figures by Country
- 5.4.1 North America Short-acting Nicotine Product Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Short-acting Nicotine Product Sales by Country (2021-2032)
- 5.4.3 North America Short-acting Nicotine Product Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Short-acting Nicotine Product Market Facts & Figures by Country
- 5.5.1 Europe Short-acting Nicotine Product Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Short-acting Nicotine Product Sales by Country (2021-2032)
- 5.5.3 Europe Short-acting Nicotine Product Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Short-acting Nicotine Product Market Facts & Figures by Country
- 5.6.1 Asia Pacific Short-acting Nicotine Product Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Short-acting Nicotine Product Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Short-acting Nicotine Product Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Short-acting Nicotine Product Market Facts & Figures by Country
- 5.7.1 South America Short-acting Nicotine Product Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Short-acting Nicotine Product Sales by Country (2021-2032)
- 5.7.3 South America Short-acting Nicotine Product Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Short-acting Nicotine Product Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Short-acting Nicotine Product Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Short-acting Nicotine Product Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Short-acting Nicotine Product Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Short-acting Nicotine Product Sales by Type (2021-2032)
- 6.1.1 Global Short-acting Nicotine Product Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Short-acting Nicotine Product Sales Market Share by Type (2021-2032)
- 6.2 Global Short-acting Nicotine Product Revenue by Type (2021-2032)
- 6.2.1 Global Short-acting Nicotine Product Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Short-acting Nicotine Product Revenue Market Share by Type (2021-2032)
- 6.3 Global Short-acting Nicotine Product Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Short-acting Nicotine Product Sales by Application (2021-2032)
- 7.1.1 Global Short-acting Nicotine Product Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Short-acting Nicotine Product Sales Market Share by Application (2021-2032)
- 7.2 Global Short-acting Nicotine Product Revenue by Application (2021-2032)
- 7.2.1 Global Short-acting Nicotine Product Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Short-acting Nicotine Product Revenue Market Share by Application (2021-2032)
- 7.3 Global Short-acting Nicotine Product Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Short-acting Nicotine Product Value Chain Analysis
- 8.1.1 Short-acting Nicotine Product Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Short-acting Nicotine Product Production Mode & Process
- 8.2 Short-acting Nicotine Product Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Short-acting Nicotine Product Distributors
- 8.2.3 Short-acting Nicotine Product Customers
9 Global Short-acting Nicotine Product Analyzing Market Dynamics
- 9.1 Short-acting Nicotine Product Industry Trends
- 9.2 Short-acting Nicotine Product Industry Drivers
- 9.3 Short-acting Nicotine Product Industry Opportunities and Challenges
- 9.4 Short-acting Nicotine Product Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst